%PDF-1.4
%
1 0 obj
<>stream
iText 4.2.0 by 1T3XT2018-10-27T15:26:55+05:30Arbortext Advanced Print Publisher2019-01-31T07:59:31-08:002019-01-31T07:59:31-08:00uuid:8addd02c-2a8d-4824-a074-0375b52bef83uuid:9735c38c-787b-4f5b-aca7-e8422204bc96JournalAmyloid© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.1350-61291744-2818253180-18818018810.1080/13506129.2018.1503593https://doi.org/10.1080/13506129.2018.1503593application/pdf10.1080/13506129.2018.1503593en-USHereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trialTaylor & FrancisAmyloid, 2018. doi: 10.1080/13506129.2018.1503593Waddington-Cruz MarciaAckermann Elizabeth J.Polydefkis MichaelHeitner Stephen B.Dyck Peter J.Barroso Fabio A.Wang Annabel K.Berk John L.Dyck P. James B.Monia Brett P.Hughes Steven G.Tai LiJesse Kwoh T.Jung Shiangtung W.Coelho TeresaBenson Merrill D.Gertz Morie A.Transthyretinamyloidosispolyneuropathycardiomyopathyquality of lifeVoR2018-08-31truewww.tandfonline.com10.1080/13506129.2018.1503593www.tandfonline.comtrue2018-08-3110.1080/13506129.2018.1503593
endstream
endobj
4 0 obj
<>stream
xZɎ4
SX־ 9>%s$/y)'30TT~`l\v⢉KdOGK[^]u&Zi ք[k.o߭u7~ %zZS^{{p{;~c=xh~hWE/tΰ;oݩ>懤Q4{_~X^qV]Y۩&/uWr,ѢEJE\fXwqtq8#$
u״B2-1+||Wf]w13{'KM-C..8\j,o4yil_Wϓ5mbO?}1?j?͛Zt?Ѥ^l^?/ ""Fbg_JVD>J/r&ť5
`o إUɱ !O<Γ.<эywFG:Dp{Za_dpu/A=)HAWsLѱd4&E|RpٰFԭ_m1|ݕ/߱Cv$X֏ %]~%QfZ^g;O:ڪJsI]Xì}ȶAy
g?DyHkG].yYg9?љm~fI9H\=W#D_~@Mr5eX[Z
y环~H;
TC䂴cNq]EX1fn__8lQFe5g'zHo=o$.V\AB` d{ax]$!
%6|z
T$.Q U4MyRPDVf$ AaeT`sowlTspYy3ΫYS8UT&BE2>&Ng>aqZ8Ft)A|7ڡZDCjlQ+<˺]B
GDᦨ&TEק\MimZ8ـý9T0Nt$p
H{D{UYW/KlJZC
\\Vs
$;HS%ImAE`^yM0?#aXm,V3gD